MET and ductal breast carcinoma in situ: Several cell surface markers have been proposed as targets for the molecular imaging of DCIS, including IGF1-R, VEGFr, HER2, EGFR, MET, CD44v6, GLUT1, CA-XII, and mammaglobin [35].